Prescribers & Clinics
Resources and governance insight for clinicians and healthcare providers.
Prescribers & Clinics · page 2
- Prescribers & Clinics
Curaleaf International Launches CPD-Accredited Education Platform for UK Cannabis Prescribers
Curaleaf International has launched a free CPD-accredited online education platform for UK healthcare professionals to help close the training gap the country’s professional medical community continues to face.
- M&A Activity
Sanity Group Deepens Swiss Footprint With Astrasana Distribution Deal
Sanity Group has announced a new distribution partnership with Swiss cannabis operator Astrasana Holding AG, further expanding its footprint in the closely watched Swiss market.
- Medical Cannabis
Do 10 Doctors Really Prescribe Half of England’s Medical Cannabis?
The UK’s medical cannabis market has long been a locked box when it comes to reliable data.
- Medical Cannabis
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries
Curaleaf Laboratories Becomes First UK Manufacturer of Medical Cannabis Suppositories and Pessaries Curaleaf Laboratories today announced a significant milestone in the advancement of medical cannabis treatments in the United Kingdom, becoming the first licensed manufacturer in the country to develop and produce medical cannabis suppositories and pessaries.
- Interviews
Bring It On: Meet the Cannabis CMO Welcoming Scrutiny With Open Arms
Scrutiny of the UK’s medical cannabis industry has rarely, if ever, been so acute since it was legalised in 2018.
- Opinion
Is the ‘Commercial Scale’ of Medical Cannabis in the UK Inappropriate?
As the UK’s medical cannabis industry continues to come under fierce scrutiny from the country’s mainstream media, James Duckenfield, CEO of UK-based cannabis cultivator Glass Pharms, argues that the focus should be on ensuring compliance with the existing regulatory framework rather than sensationalising a prescribing rate that remains a small fraction of demonstrable clinical need.
- Cultivation
New Zealand’s Medical Cannabis Market Growth Slows as Major Operator Calls in Administrators
New Zealand’s medical cannabis market grew a further 25% in 2025, according to the latest official figures, seeing the country cement its position as one of the lesser-discussed but most exciting markets on the planet.
- Industry Trends
Germany’s Medical Cannabis Product Range Quadruples as Prices Fall 30%
Business of Cannabis is excited to announce the launch of German Cannabis Intel: Insights & Market Data, the inaugural report in our new quarterly series in partnership with Grünhorn.
- Industry Trends
Deals, Courts and Coalition Splits: Germany’s Cannabis Market Braces for Change
It’s now five months since the German Federal Cabinet adopted draft amendments to its pivotal Medizinal-Cannabisgesetzes (MedCanG) bill, and its finalisation is expected in the coming weeks.
- Medical Cannabis
Why Medical Cannabis Clinics Should Be Knocking on Union Doors
When a crew trainer at a fast food restaurant told her manager she had recently been prescribed medical cannabis, she came prepared.
- Industry Trends
The Scramble for Europe
Last month, the German cannabis market saw its most significant consolidation deal to date, as Canadian heavyweight Organigram announced plans to acquire Sanity Group in a deal worth up to €250m.
- Prescribers & Clinics
Evidena Care Launches Switzerland’s First Integrated Medical Cannabis Market Comparison Platform
Evidena Care, one of Switzerland’s leading specialised telemedicine providers for medical cannabis, has announced the launch of a nationwide online comparison platform for prescription-based medical cannabis products.
